On April 30, 2026, Bimergen Energy Corporation (“Bimergen”) Compensation Committee entered into amendments of its employment agreements with Robert J. Brilon as Co-Chief Executive Officer and Chief Financial Officer (the “Brilon Agreement”) and Cole W. Johnson as Co-Chief Executive Officer and President (the “Johnson Agreement”) effective April 1, 2026.
On May 4, 2026, Anthony K. McDonald, the Company’s President and a member of the Company’s Board of Directors, resigned as President and as a director of the Company.
On May 4, 2026, Anthony K. McDonald, the Company’s President and a member of the Company’s Board of Directors, resigned as President and as a director of the Company.
On Tuesday May 5, 2026, Hamilton Insurance Group, Ltd. (the “Company”) held its 2026 Annual General Meeting of Shareholders (the “2026 Annual Meeting”) at which all 11 Class B director nominees were elected to the Company's Board of Directors (the “Board”), including first time nominee Peter W. Wilson.
On May 5, 2026, the Boards of Directors of Orrstown Financial Services, Inc. (the “Company”) and its wholly-owned subsidiary Orrstown Bank (the “Bank”) elected Adam L. Metz as the President, Chief Executive Officer and Director of the Company and the Bank, respectively, effective upon the retirement of Thomas R. Quinn, Jr. from those positions with the Company and the Bank at the close of business on June 1, 2026
On May 5, 2026, the Board of Directors of SkinHealth Systems Inc. (the “Company”) terminated Mr. Ronald Menezes' employment as Chief Revenue Officer of the Company without cause, effective as of May 5, 2026.
On May 5, 2026, the Board of Directors (the “Board”) of General Mills, Inc. (the “Company”) elected Dana M. McNabb Chief Operating Officer of the Company effective June 1, 2026.
On May 1, 2026, the Board of Directors ("Board") of Actuate Therapeutics, Inc. (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee, appointed Martin H. Huber, MD, to the Board.
On May 1, 2026, ModuLink Inc. (the “Company”) appointed Dr. Henry Wah Shing Lam (“Dr. Lam”), aged 31, as Chief Technology Officer (“CTO”) of the Company.
On April 30, 2026, a special committee (the "Special Committee") composed of independent directors of the Board of Directors (the "Board") of Anavex Life Sciences Corp. (the "Company") terminated the employment of Christopher Missling, PhD as the Company's Chief Executive Officer for Cause (as defined in the Employment Agreement, dated as of June 27, 2013, between Dr. Missling and the Company, as amended and restated), effective immediately, for, among other things, conduct that the Special Committee believed was inconsistent with Company policy.
On May 5, 2026, the Board of Directors of the Company elected Jennifer G. Newstead as a Director of the Company, effective as of August 3, 2026 (the “Effective Date”).
On May 5, 2026, Integra LifeSciences Holdings Corporation (the "Company") announced the appointment of Dr. Stuart M. Essig to serve as its President and Chief Executive Officer, effective as of May 1, 2026 (the "Start Date").
Dr. Essig succeeds Mojdeh Poul, who is departing from her role as the Company's President and Chief Executive Officer and as a member of the Company's Board of Directors (the "Board") effective as of the end of the day on April 30, 2026 (the "Separation Date").
Dr. Essig succeeds Mojdeh Poul, who is departing from her role as the Company's President and Chief Executive Officer and as a member of the Company's Board of Directors (the "Board") effective as of the end of the day on April 30, 2026 (the "Separation Date").
On May 5, 2026, Option Care Health, Inc. (the “Company”) announced that Christopher L. Grashoff will depart from his role as Chief Growth Officer of the Company, effective May 8, 2026.
The Board has appointed Roger Carlile, the Company’s Chief Executive Officer, to serve as Chair of the Board upon Mr. Pisano’s retirement from the Board.
each of David A. Pace, John Moore, Bradley Radoff, Shaun Mara, Terence O'Brien, and Waheed Zaman, the members of the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company at the Effective Time
William L. Wann Jr., Will Foster and Drew Dutton, the members of the board of directors of Merger Sub immediately prior to the Effective Time became the directors of the Surviving Corporation as of the Effective Time
the board of the Surviving Corporation appointed Mr. Wann as President and Chief Executive Officer and Tiffany Moseley as Senior Vice President and Chief Financial Officer
each of David A. Pace, John Moore, Bradley Radoff, Shaun Mara, Terence O'Brien, and Waheed Zaman, the members of the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company at the Effective Time
the board of the Surviving Corporation appointed Mr. Wann as President and Chief Executive Officer and Tiffany Moseley as Senior Vice President and Chief Financial Officer
each of David A. Pace, John Moore, Bradley Radoff, Shaun Mara, Terence O'Brien, and Waheed Zaman, the members of the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company at the Effective Time
each of David A. Pace, John Moore, Bradley Radoff, Shaun Mara, Terence O'Brien, and Waheed Zaman, the members of the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company at the Effective Time
William L. Wann Jr., Will Foster and Drew Dutton, the members of the board of directors of Merger Sub immediately prior to the Effective Time became the directors of the Surviving Corporation as of the Effective Time
each of David A. Pace, John Moore, Bradley Radoff, Shaun Mara, Terence O'Brien, and Waheed Zaman, the members of the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company at the Effective Time
each of David A. Pace, John Moore, Bradley Radoff, Shaun Mara, Terence O'Brien, and Waheed Zaman, the members of the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company at the Effective Time
William L. Wann Jr., Will Foster and Drew Dutton, the members of the board of directors of Merger Sub immediately prior to the Effective Time became the directors of the Surviving Corporation as of the Effective Time
Appointed
Andrew T. Scribner
executive vice president and chief financial officer (principal financial officer)
On May 5, 2026, CF Industries Holdings, Inc. ("CF Industries" or the "Company") announced that Andrew T. Scribner has been elected executive vice president and chief financial officer (principal financial officer), effective May 26, 2026 (the "Effective Date").
Departed
Ellen M. Schum
Executive Vice President and President of Specialty and Interim President of Meals
On May, 1, 2026, Andrew D. Vogel, our Executive Vice President and President of Spices & Flavor Solutions, terminated his employment with B&G Foods as of the close of business that day.
Departed
J. Ross Franklin
Vice President, Chief Financial Officer and Secretary
On April 29, 2026, J. Ross Franklin notified Atlantic American Corporation (the “Company”) of his decision to resign as Vice President, Chief Financial Officer and Secretary of the Company, effective May 27, 2026.
Effective upon Mr. Ware’s appointment as the CFO, Justin Vu resigned as Chief Financial Officer of the Company as well as all other positions with the Company, its subsidiaries and its affiliates.
Effective April 29, 2026, iAnthus Capital Holdings, Inc. (the “Company”) appointed Jason Ware, age 52, as the Company’s Chief Financial Officer (the “CFO”).
On April 30, 2026, Nate Zwald, Lauren Singer, Jean Rogers, Jeffrey Tepper and Ben Veres were appointed as members of the Board of Directors of the Company (the “ Board ”).
On April 30, 2026, Nate Zwald, Lauren Singer, Jean Rogers, Jeffrey Tepper and Ben Veres were appointed as members of the Board of Directors of the Company (the “ Board ”).
On April 30, 2026, Nate Zwald, Lauren Singer, Jean Rogers, Jeffrey Tepper and Ben Veres were appointed as members of the Board of Directors of the Company (the “ Board ”).
On April 30, 2026, Nate Zwald, Lauren Singer, Jean Rogers, Jeffrey Tepper and Ben Veres were appointed as members of the Board of Directors of the Company (the “ Board ”).
On April 30, 2026, Nate Zwald, Lauren Singer, Jean Rogers, Jeffrey Tepper and Ben Veres were appointed as members of the Board of Directors of the Company (the “ Board ”).
On April 29, 2026, the Board of Directors of the Company (the “Board”) appointed Anthony Carroll as the Company’s President and Chief Executive Officer, effective as of April 29, 2026.
On May 4, 2026, the board of directors (the “Board”) of Lithium Americas Corp. (the “Company”) appointed Clayton Walker to serve as a member of the Board, effective May 4, 2026.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.